Neuroscientist Ben Barres has died
med.stanford.edu> “If you took the Barres lab out of the field of glial studies, there would be no field,” Raff said.
The highest of compliments. RIP
Prior to his insights, glia were just thought to be little more than structural support and insulation for neurons. The truth of course is so much more interesting.
Baruch dayan emet.
In addition to being an incredibly productive, paradigm-shifting scientist, Dr. Barres was also honest and down to earth about the realities of the field. I'd recommend anyone going in to any type of graduate study to read his essay on how to choose na graduate advisor: http://www.cell.com/neuron/abstract/S0896-6273(13)00907-0
I quit academia, frustrated at how bureaucratic it was and how impossible it seemed to become a Great Scientist. Very inspiring to read about the lives of those who make it against all odds.
May the work and memory of Ben Barres carry the next generations of scientists.
“died on Dec. 27, 20 months after being diagnosed with pancreatic cancer. He was 63.”
A form of cancer where we have made almost zero progress. What’s it going to take to get more research?
It has already been 10 years: https://www.cmu.edu/randyslecture/
Problem is also that it is not easy to diagnose in early stages, so you end up with most patients diagnosed in stage 4.
It's a difficult problem etc etc
The real answer is that the life sciences are currently in a medieval phase. It's like doing physics without algebra or calculus. We should certainly not expect any regular progress. It is extraordinarily inefficient.
I understand what you are trying to say. Yes. This is a sort of a dark age for all science related. A few well supported islands in an ocean of hostile politics
it’s not like people aren’t trying. it’s just a real bastard of a disease.
I didn’t say people weren’t trying. I was asking for more research. Pancreatic cancer is not generously funded. Most would argue that it’s underfunded.
https://well.blogs.nytimes.com/2008/03/06/cancer-funding-doe...
https://www.cancer.org/research/currently-funded-cancer-rese...
It's not just funding.
For one, the dynamics of the known molecular pathways involved are complex [1], and so far non-trivial to manipulate.
Furthermore, even with an actionable mechanism, targeting the tumor itself is highly non-trivial, due to physiology alone. (See e.g. [2]).
The best know transgender scientist